SA wants to buy the two-monthly anti-HIV jab - 18 days after US donation deal
The national health department has asked drugmakers to submit prices, and how much they can make, of the two-monthly anti-HIV jab, CAB-LA.
"It's a signal to the market that this is a medicine that is being considered for inclusion in the HIV care package being offered."cabotegravirUntil now, however, the health department has had no plans of buying the medicine because it's so expensive. to donors and low- and middle-income countries, such as South Africa, which works out to roughly four times more than what the government pays for a two-month supply of the daily HIV prevention pill.
In places where the chance for new infections is lower, 200 people have to take HIV prevention drugs to stop one new infection. to three Indian generic drugmakers — Airobindo, Cipla and Viatris — through the Medicines Patent Pool to make cheaper versions of CAB-LA, as the companies would receive the drug's recipe, and ViiV would also share the know-how of how to apply the recipe, without the generic companies having to cover the cost of developing the drug.
She says the dates for the three-year period that the request for information document, which was published on 16 July, refers to, have not yet been established, and that the department"will have more information about when suppliers are able to supply". How much CAB-LA the health department would need would depend on how open people are to getting the jab and if they'd be prepared to use it consistently.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Africa: 'We Have to Build Solidarity Across Movements' - Clark on Ending HIV Pandemic #Aids2024Diplomacy and foreign policy prescribe health as a critical component that impacts economic prosperity, global development, and security. Policy decisions in these areas directly influence health outcomes and the spread of disease.
Read more »
Africa: New Lab Test for HIV Strains Found in Africa Smooths Road to CureA cure for HIV is critically important for Africa due to the continent's heavy burden from the disease. Africa bears a disproportionately high HIV prevalence, with around 8 million people living with HIV in South Africa alone.
Read more »
HIV prevalence down from 14% to 12.7%, females still twice as likely to test positiveA study shows about 7.8 million people were living with HIV in South Africa in 2022, down from 7.9 million in 2017.
Read more »
SA shows gains in HIV prevention and treatment, survey findsSA shows gains in HIV prevention and treatment, survey finds
Read more »
Africa: Why HIV Risks Are Rising in Older AdultsMore and more older people are living with HIV and AIDS.
Read more »
Africa: Why People with Disabilities Face an Uphill Battle with HIVDouble the stigma, double the challenge
Read more »